Association between quantitative high-risk human papillomavirus DNA load and cervical intraepithelial neoplasm risk

Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2544-9. doi: 10.1158/1055-9965.EPI-05-0240.

Abstract

Human papillomavirus (HPV) infection is a high-risk factor for cervical intraepithelial neoplasm (CIN) but the association between the quantitative HPV DNA load and the severity of CIN remains controversial. We conducted a community study to investigate the correlation between the two. Potential study subjects were selected through Pap smear screening in Kaohsiung County, Taiwan. Ninety-one subjects with either their first case of inflammation or > or =CIN1 by biopsy confirmation were assigned to a case group; 175 normal subjects with negative findings by Pap smears or biopsies were assigned to a control group. Cervical HPV load was detected with Hybrid Capture II assay for high-risk HPV infection, with nested PCR for high- and low-risk HPV infection, and with type-specific PCR for HPV type 16 (HPV-16). Individuals with positive high-risk HPV infection had an increased risk of developing CIN. Compared with HPV-negative subjects, the odds ratios were 32.2 [95% confidence interval (95% CI), 10.4-99.5] for subjects with CIN1, 37.2 (95% CI, 7.4-187.6) for subjects with CIN2, and 68.3 (95% CI, 14.1-328.5) for subjects with > or =CIN3 after adjusting for other confounding factors. The similar trend was also found among the HPV-16-negative individuals. In addition, high-risk HPV DNA load levels were highly correlated with the different grades of CINs in the overall population (Spearman's correlation coefficient r = 0.67, P < 0.0001, n = 266) and the HPV-16-negative population (Spearman's correlation coefficient r = 0.58, P < 0.0001, n = 234). We concluded that high-risk HPV infection, irrespective of HPV-16 infection, was highly and positively associated with the development of CIN.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Case-Control Studies
  • DNA, Viral / analysis
  • Female
  • Human papillomavirus 16 / genetics*
  • Human papillomavirus 16 / pathogenicity
  • Humans
  • Middle Aged
  • Papanicolaou Test
  • Papillomavirus Infections / complications*
  • Polymerase Chain Reaction
  • Risk Factors
  • Uterine Cervical Dysplasia / etiology*
  • Uterine Cervical Dysplasia / virology*
  • Uterine Cervical Neoplasms / etiology*
  • Uterine Cervical Neoplasms / virology*
  • Vaginal Smears
  • Viral Load*

Substances

  • DNA, Viral